Webinar recording available now: the future of mRNA analysis

Watch now: Discover current & advanced analytical technologies for the comprehensive characterization of mRNA and its impurities

 

Catch up on our recently sponsored expert webinar around the future of mRNA analysis. The discussed study highlights opportunities for improving the analytical characterization of IVT mRNA, contributing to the refinement of mRNA production for mRNA-based cancer therapies and vaccines.

Learn more about the advanced characterization utilizing techniques like ion-pair reversed-phase liquid chromatography, capillary gel electrophoresis, mass photometry, and native mass spectrometry for precise mRNA and its impurities.

Expert speaker: Axel Guilbaud, Principal Scientist, Genentech

Axel Guilbaud, Genentech, mRNA

Watch webinar recording on the future of mRNA analysis

Form Successfully Submitted!
Thank you for your submission!
text

During this webinar, we explore the versatile platform of in vitro transcribed mRNA and its potential for biotechnological applications. We delve into the importance of mRNA-based cancer therapies and vaccines, while addressing the challenges posed by impurities during IVT production.

Axel Guilbaud (Genentech/Roche) presents pioneering research on the comprehensive profiling of IVT mRNA impurities using current and advanced analytical tools. Techniques such as ion-pair reversed-phase liquid chromatography, capillary gel electrophoresis, mass photometry, and native mass spectrometry are discussed, providing insights into precise mRNA and impurity analysis.